Stocks · News reference

8-K filing — Nexalin Technology, Inc. (NXL)

Jul 29, 2026, 9:25 PMSEC EDGAR

Filed: 2026-07-29 AccNo: 0001829126-26-008047 Size: 191 KB Item 1.01: Entry into a Material Definitive Agreement

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: edgar
Observed: Jul 29, 2026, 9:25 PM
Checked: Jul 29, 2026, 9:25 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 27, 2026, 4:53 PMBenzinga Newsdesk
Nexalin Technology shares are trading lower after the company announced a 1-for-30 reverse stock split.
Read original at benzinga
NXL
SEC EDGARAug 27, 2026, 11:30 AMSEC EDGAR
8-K filing — Nexalin Technology, Inc. (NXL)
Filed: 2026-08-27 AccNo: 0001829126-26-009387 Size: 241 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgar
NXL
BenzingaAug 27, 2026, 11:26 AMBenzinga Newsdesk
Nexalin Technology Announces 1-For-30 Reverse Stock Split, Effective August 28
Read original at benzinga
NXL
BenzingaJun 16, 2026, 1:18 PMBenzinga Newsdesk
Nexalin Technology To Present Clinical Data Showing 77.8% Anxiety Response Rate, Durable 8-Week Benefits, And No Serious Adverse Events From Its 15 mA, 77.5 Hz DIFS Deep-Brain Stimulation Platform, At 2026 NYC Neuromodulation Conference
Read original at benzinga
NXL